Back Back
Pamorelin Triptorelin Powder Injection
Get Price Quote
About Pamorelin LA 3.75 mg Injection Pamorelin LA 3.75 mg Injection belongs to the class of 'anti-neoplastic agents', primarily used to treat prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Prostate cancer is the prostate gland's cancer (a small gland under the bladder secretes fluid that nourishes and protects sperm) found only in men. Endometriosis is a disorder in which tissue lining the uterus grows outside the uterine cavity. Precocious puberty occurs when a child's body changes into that of an adult or experiences puberty too soon. Pamorelin LA 3.75 mg Injection contains Triptorelin that belongs to the class of gonadotropin-releasing hormone (GnRH) agonists. Triptorelin is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. It works by inhibiting the synthesis of the natural male hormone, testosterone in men and oestrogen in women. The lowering of testosterone hormone levels in men helps slows down the growth of cancer cells in prostate cancer. Use Pamorelin LA 3.75 mg Injection as prescribed by your doctor. Your doctor will decide the dosage depending on your medical condition. The common side effects of Pamorelin LA 3.75 mg Injection include hot flashes, decreased sexual interest, shrinking of the testicles, breast tenderness or swelling, dizziness, headache, flu symptoms, nausea, vomiting, diarrhoea, upset stomach and swelling in legs. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor. Do not take or stop this medicine, if the doctor did not advise you to do so. Before starting Pamorelin LA 3.75 mg Injection, let your doctor know if you have any medical history of liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Pamorelin LA 3.75 mg Injection is not indicated for use in pregnant and breastfeeding women. Pamorelin LA 3.75 mg Injection may make you feel dizzy, hence drive when you are alert only. Pamorelin LA 3.75 mg Injection is not recommended for children below two years of age. Uses of Pamorelin LA 3.75 mg Injection Prostate cancer, endometriosis and precocious puberty. Medicinal Benefits Pamorelin LA 3.75 mg Injection contains Triptorelin, a gonadotropin-releasing hormone (GnRH) agonist. It treats prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Pamorelin LA 3.75 mg Injection is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. Being an anti-neoplastic or anticancer agent, Pamorelin LA 3.75 mg Injection works by lowering testosterone levels in men that help stop the growth of cancer cells in prostate cancer. Pamorelin LA 3.75 mg Injection reduces oestrogen (a hormone required for the development and regulation of the female reproductive system and secondary sexual characteristics) levels in women, thus helps in shrinking of endometriosis. Pamorelin LA 3.75 mg Injection also has the role of a contraceptive drug. Directions for UseIntramuscular injection: Injection form of Pamorelin LA 3.75 mg Injection will be given into the muscle of your buttocks or thigh by a health care professional.StorageStore in a cool and dry place away from sunlightSide Effects of Pamorelin LA 3.75 mg Injection Hot flashes Decreased sexual interest Shrinking of the testicles Breast tenderness or swelling Dizziness Headache Flu Nausea Vomiting Diarrhoea Upset stomach Swelling in legs
